Literature DB >> 517237

Effect of pancreatic kallikrein, sperm acrosin and high molecular weight (HMW) kininogen on cervical mucus penetration ability of seminal plasma-free human spermatozoa.

W B Schill, G Preissler, B Dittmann, W P Muller.   

Abstract

Bradykinin is able to stimulate sperm migration of SPFS; HMW kininogen does not effect sperm migration of SPFS; Kallikrein and acrosin induce small stimulation of sperm migration of SPFS indicating traces of kininogen attached to the sperm surface enabling liberation of kinins; In the presence of kininogen, kallikrein and acrosin significantly improve cervical mucus penetration of SPFS; Lastly, from the presented studies there is experimental evidence that acrosin is involved in stimulation of sperm migration within the female genital tract due to liberation of kinins from kininogen (see Figure 7.).

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 517237

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  5 in total

1.  Biotechnological aspects of the production of human pro-kallikrein using the AcNPV-baculovirus-expression system.

Authors:  G Fertig; H P Rahn; A Angermann; M Klöppinger; H G Miltenburger
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

2.  Determination of active, non-zymogen acrosin, proacrosin and total acrosin in different andrological patients.

Authors:  W B Schill
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

3.  Cloning and expression of human salivary-gland kallikrein in Escherichia coli.

Authors:  A Angermann; C Bergmann; H Appelhans
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

4.  Effects of protease inhibitors and substrates on motility of mammalian spermatozoa.

Authors:  E de Lamirande; C Gagnon
Journal:  J Cell Biol       Date:  1986-04       Impact factor: 10.539

Review 5.  Sperm preparation for ART.

Authors:  Ralf R Henkel; Wolf-Bernhard Schill
Journal:  Reprod Biol Endocrinol       Date:  2003-11-14       Impact factor: 5.211

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.